Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-density lipoproteins and atherosclerosis.

Daniel J Rader1

  • 1University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. rader@mail.med.upenn.edu

The American Journal of Cardiology
|November 7, 2002
PubMed
Summary

High-density lipoproteins (HDL) are crucial for cardiovascular health. Research explores HDL metabolism and its role in preventing atherosclerosis, a key factor in heart disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.

The New England journal of medicine·2017
Same author

Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.

Nature genetics·2017
Same author

Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.

Cell reports·2017
Same author

Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.

Circulation research·2017
Same author

Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.

The Journal of clinical investigation·2017
Same author

Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis.

The Journal of biological chemistry·2017

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • High-density lipoproteins (HDL) are linked to atherosclerotic cardiovascular disease risk.
  • Low HDL cholesterol is a significant cardiovascular risk factor.
  • Apolipoprotein (apo) A-I overexpression inhibits atherosclerosis in animal models.

Purpose of the Study:

  • To investigate the role of HDL in atherosclerosis.
  • To understand the mechanisms by which HDL inhibits atherosclerosis.
  • To evaluate HDL as a therapeutic target for cardiovascular disease.

Main Methods:

  • Review of existing clinical and animal model data on HDL and atherosclerosis.
  • Analysis of gene products involved in HDL metabolism regulation.
  • Exploration of the relationship between HDL, atherosclerosis, and cardiovascular risk factors.

Main Results:

  • HDL is strongly associated with atherosclerotic cardiovascular disease risk.
  • Low HDL cholesterol levels are a major cardiovascular risk factor.
  • Overexpression of apo A-I reduces atherosclerosis progression and induces regression in animal models.

Conclusions:

  • HDL is a potential therapeutic target for cardiovascular disease.
  • Further research is needed to fully understand HDL metabolism and its role in atherosclerosis.
  • Understanding HDL's mechanisms is crucial for developing effective cardiovascular therapies.

Related Experiment Videos